Carrier frequency of the common mutation IVS8-IG>C in DHCR7 and estimate of the expected incidence of Smith-Lemli-Opitz syndrome

被引:70
作者
Battaile, KP
Battaile, BC
Merkens, LS
Maslen, CL
Steiner, RD
机构
[1] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97201 USA
[2] Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97201 USA
[3] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA
[4] Univ Alaska Fairbanks, Juneau Ctr, Sch Fisheries & Ocean Sci, Juneau, AK USA
关键词
Smith-Lemli-Opitz syndrome; cholesterol; metabolism; statistics; population; DHCR7;
D O I
10.1006/mgme.2000.3103
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Smith-Lemli-Opitz syndrome (SLOS) is a multiple congenital anomaly/mental retardation syndrome of variable severity with an incidence previously estimated at 1 in 20,000-60,000 based on case frequency surveys, Identification of the gene defect in SLOS has made it possible to calculate the carrier frequency and estimate disease incidence using molecular methods to identify carriers. Using a previously described PCR-RFLP assay we screened 1503 anonymous blood samples from random newborn screening blood spot cards for the presence of the common SLOS mutation IVS8-1G>C in order to determine the carrier frequency. Sixteen carriers were identified in the 1503 samples. Since the frequency of the IVS8-1G>C mutation among all SLOS gene mutations is known, the overall carrier frequency for all mutations can be calculated, The calculated carrier frequency for all mutations based on this result is 1 in 30, predicting an SLOS incidence of 1 in 1590 to 1 in 13,500. The current incidence estimate may, therefore, significantly underestimate the true incidence of SLOS. This discrepancy between calculated and observed incidence could be due to undiagnosed mild cases, misdiagnosed severe cases, death prior to diagnosis, or fetal loss, More comprehensive incidence studies are needed to determine if SLOS is as common as predicted by the very high (1 in 30) carrier frequency determined in this study. (C) 2001 Academic Press.
引用
收藏
页码:67 / 71
页数:5
相关论文
共 34 条
[1]   A simple PCR-based assay allows detection of a common mutation, IVS8-1G→C, in DHCR7 in Smith-Lemli-Opitz syndrome [J].
Battaile, KP ;
Maslen, CL ;
Wassif, CA ;
Krakowiak, P ;
Porter, FD ;
Steiner, RD .
GENETIC TESTING, 1999, 3 (04) :361-363
[2]  
CHAKRABORTY R, 1993, AM J HUM GENET, V52, P1129
[3]  
Cunniff C, 1997, AM J MED GENET, V68, P263, DOI 10.1002/(SICI)1096-8628(19970131)68:3<263::AID-AJMG4>3.0.CO
[4]  
2-N
[5]  
CURRY C J R, 1987, American Journal of Medical Genetics, V26, P45, DOI 10.1002/ajmg.1320260110
[6]   Smith-Lemli-Opitz syndrome:: evidence of T93M as a common mutation of Δ7-sterol reductase in Italy and report of three novel mutations [J].
De Brasi, D ;
Esposito, T ;
Rossi, M ;
Parenti, G ;
Sperandeo, MP ;
Zuppaldi, A ;
Bardaro, T ;
Ambruzzi, MA ;
Zelante, L ;
Ciccodicola, A ;
Sebastio, G ;
D'Urso, M ;
Andria, G .
EUROPEAN JOURNAL OF HUMAN GENETICS, 1999, 7 (08) :937-940
[7]   Mutations in the Δ7-sterol reductase gene in patients with the Smith-Lemli-Opitz syndrome [J].
Fitzky, BU ;
Witsch-Baumgartner, M ;
Erdel, M ;
Lee, JN ;
Paik, YK ;
Glossmann, H ;
Utermann, G ;
Moebius, FF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (14) :8181-8186
[8]   ABNORMAL CHOLESTEROL-METABOLISM IN THE SMITH-LEMLI-OPITZ SYNDROME - REPORT OF CLINICAL AND BIOCHEMICAL FINDINGS IN 4 PATIENTS AND TREATMENT IN ONE PATIENT [J].
IRONS, M ;
ELIAS, ER ;
TINT, GS ;
SALEN, G ;
FRIEDEN, R ;
BUIE, TM ;
AMPOLA, M .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1994, 50 (04) :347-352
[9]  
Kelley RI, 1996, AM J MED GENET, V66, P478, DOI 10.1002/(SICI)1096-8628(19961230)66:4<478::AID-AJMG22>3.0.CO
[10]  
2-Q